Skip links
Companies
Japan › Astellas Pharma Inc.
Astellas Pharma Inc. logo

Astellas Pharma Inc.

Active

in

Registration No.
5010001034966
Incorporation Date
2015-10-05
Company Type
N/A
Address
Chuo Ward, Japan
Website
www.astellas.com/
Source: National Tax Agency — Corporate Number Publication Site

Astellas Pharma Inc. is a registered legal entity registered in Japan under 5010001034966, and its current status with National Tax Agency — Corporate Number Publication Site is active. The company was incorporated on 5 October 2015 and lists its registered address as Chuo Ward, Japan. 1 shareholder is on record for Astellas Pharma Inc., and since every one of them is a company rather than an individual, this particular filing does not on its own establish an ultimate beneficial owner (UBO) — identifying one would mean tracing the ownership of each shareholding company in turn. This profile is sourced directly from National Tax Agency — Corporate Number Publication Site and was last updated on 11 August 2026.

Data Provenance
This record is sourced directly from official government registries, including National Tax Agency — Corporate Number Publication Site.

View data sources →

We don’t stop at registry data.
Every company record is enriched with additional intelligence:
  • Company fundamentals
  • Corporate linkage & group structures
  • Digitized company financials
  • Firmographics — websites, social profiles, revenue and employee estimates

View full data dictionary →

Shareholders

1

One shareholder is currently on record for Astellas Pharma Inc., reflecting the kabunushi meibo (shareholder register) maintained under Articles 121-122 of the Companies Act rather than a public filing.

The largest of these is Nbc Securities, Inc. , holding 14.7% — the largest recorded stake.

Because the shareholder shown is a company rather than an individual, the ownership chain continues above this level, and no beneficial owner can be established from this filing alone.

Shareholder Type Holding Source Document
Nbc Securities, Inc. 14.7% National Tax Agency — Corporate Number Publication Site

View all shareholders & beneficial ownership
Full cap table, ownership percentages, and ultimate beneficial owners resolved down to the natural person.

View all shareholders →

Officers

5

The President, Ceo & Director of Astellas Pharma Inc. on record is Naoki Okamura Bsc; 5 officers are shown here, filed with National Tax Agency — Corporate Number Publication Site.

The register reports 15 officers in total, including past appointments, though only the 5 most relevant records are shown here.

Management authority at Astellas Pharma Inc. sits with these individuals, not with shareholders, who are covered separately and hold ownership rather than control.

The source filing doesn't specify representation authority — whether officers can act individually or must sign jointly to bind the company — so that detail isn't available here.

NO
Naoki Okamura Bsc ACTIVE

Residence
🇯🇵 Japan
Occupation
President, Ceo & Director

ON
OKAMURA NAOKI ACTIVE

Residence
🇯🇵 Japan
Occupation
Chief Executive Officer

KS
Katsuyoshi Sugita ACTIVE

Residence
🇯🇵 Japan
Occupation
Executive Vp, Chief People Officer & Representative Director

NT
Nobuaki Tanaka ACTIVE

Residence
🇯🇵 Japan
Occupation
President Of Japan Commercial & Senior Corporate Executive

TG
Tatjana Govic J.d. ACTIVE

Residence
🇯🇵 Japan
Occupation
General Counsel, Chief Ethics & Compliance Officer

View all officers & directors
Complete appointment history, representation authority, and officer-level filings across jurisdictions.

View all officers →

Group Structure

Astellas Pharma Inc. has no recorded parent company — it sits at the top of its own group structure, with 2 subsidiaries recorded beneath it across 1 jurisdiction. Each of these downward relationships is derived rather than filed: resolved by matching entities across the registry network, not stated directly in a single document.

Those 2 subsidiaries span Japan jurisdiction, though this list should not be read as complete — subsidiaries only become visible here where shareholder data has actually been filed with a register, so holdings in jurisdictions without that filing simply won't appear.

Ultimate HQ
Astellas Pharma Inc.
Japan
ASTELLAS PHARMA CAPABILITY CENTRE INDIA PRIVATE LIMITED
IN U62099KA2025FTC198796

Astellas B.V.
NL 33193274

Explore the full group structure
Map the complete corporate hierarchy: parent companies, subsidiaries, and cross-border ownership chains.

View full group structure →

Need the full UBO picture on Astellas Pharma Inc.?

Get complete shareholder and officer records, ultimate beneficial owner resolution, and ongoing ownership monitoring.

Frequently Asked Questions

Who owns Astellas Pharma Inc.?

One shareholder is currently on record for Astellas Pharma Inc., reflecting the kabunushi meibo (shareholder register) maintained under Articles 121-122 of the Companies Act rather than a public filing. The largest of these is Nbc Securities, Inc. , holding 14.7% — the largest recorded stake. Because the shareholder shown is a company rather than an individual, the ownership chain continues above this level, and no beneficial owner can be established from this filing alone.

Who is Astellas Pharma Inc.'s UBO (Ultimate Beneficial Owner)?

Every shareholder recorded for Astellas Pharma Inc. is itself a company rather than a natural person, so no Ultimate Beneficial Owner (UBO) is identified at this level; establishing one would require tracing the ownership of each shareholding company in turn.

How many shareholders does Astellas Pharma Inc. have on record?

1 shareholder is shown on record for Astellas Pharma Inc..

What is Astellas Pharma Inc.'s company registration number?

Astellas Pharma Inc.'s registration number is 5010001034966, filed with National Tax Agency — Corporate Number Publication Site in Japan. Its current status on the register is active.

Is Astellas Pharma Inc. still an active company?

Astellas Pharma Inc.'s status on National Tax Agency — Corporate Number Publication Site is listed as active.

When was Astellas Pharma Inc. incorporated?

Astellas Pharma Inc. was incorporated on 5 October 2015, according to National Tax Agency — Corporate Number Publication Site.

What is Astellas Pharma Inc.'s registered address?

The registered address on file for Astellas Pharma Inc. is Chuo Ward, Japan.

Who are the officers/directors of Astellas Pharma Inc.?

The President, Ceo & Director of Astellas Pharma Inc. on record is Naoki Okamura Bsc; 5 officers are shown here, filed with National Tax Agency — Corporate Number Publication Site. Management authority at Astellas Pharma Inc. sits with these individuals, not with shareholders, who are covered separately and hold ownership rather than control.

Does Astellas Pharma Inc. have a parent company or subsidiaries?

Astellas Pharma Inc. has no recorded parent company — it sits at the top of its own group structure, with 2 subsidiaries recorded beneath it across 1 jurisdiction. Those 2 subsidiaries span Japan jurisdiction, though this list should not be read as complete — subsidiaries only become visible here where shareholder data has actually been filed with a register, so holdings in jurisdictions without that filing simply won't appear.

Can Zavia monitor changes to Astellas Pharma Inc.'s ownership over time?

This profile reflects a point-in-time snapshot from National Tax Agency — Corporate Number Publication Site. Zavia's monitoring API can track changes to Astellas Pharma Inc.'s registered shareholders, officers, and group structure going forward, flagging updates as they're filed rather than requiring a manual recheck.

Can I access Astellas Pharma Inc.'s data through an API?

Yes. Zavia's API connects directly to official government ownership registries across 195 countries and territories, including Japan, so records like Astellas Pharma Inc.'s registration, shareholder, UBO, and group-structure data can be queried programmatically instead of viewed one page at a time.

Where does this company information come from, and how current is it?

This record is sourced directly from National Tax Agency — Corporate Number Publication Site and was last synced on 11 August 2026.

This website uses cookies to improve your web experience.